M3-dCAS9-DNMT3A
(Plasmid
#220237)
-
PurposeExpresses dCAS9-DNMT3A fusion protein and double marker GFP-T2A-Puro under independent promoters
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 220237 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepdCas9-DNMT3A-EGFP
- Total vector size (bp) 11740
-
Vector typeMammalian Expression, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert 1
-
Gene/Insert nameM3-dCAS9-DNMT3A (dCas9-3A)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)6279
Gene/Insert 2
-
Gene/Insert nameGFP-T2A-Puro
-
SpeciesH. sapiens (human)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2025.03.15.641804 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
M3-dCAS9-DNMT3A was a gift from Maja Jagodic (Addgene plasmid # 220237 ; http://n2t.net/addgene:220237 ; RRID:Addgene_220237) -
For your References section:
Systematic comparison of dCas9-based DNA methylation epimodifiers over time indicates efficient on-target and widespread off-target effects. Kakhki MP, Rangani F, Ewing E, Cucuzza CS, Zheleznyakova G, Kalomoiri M, Badam TVS, Covacu R, Andreou I, Needhamsen M, Kular L, Jagodic M. bioRxiv 2025.03.15.641804; doi: 10.1101/2025.03.15.641804 10.1101/2025.03.15.641804